Dystonia Medical Research Foundation Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Dystonia Medical Research Foundation's estimated annual revenue is currently $9.1M per year.(i)
  • Dystonia Medical Research Foundation's estimated revenue per employee is $216,000

Employee Data

  • Dystonia Medical Research Foundation has 42 Employees.(i)
  • Dystonia Medical Research Foundation grew their employee count by 5% last year.

Dystonia Medical Research Foundation's People

NameTitleEmail/Phone
1
Executive DirectorReveal Email/Phone
2
Development DirectorReveal Email/Phone
3
Science and Technology ManagerReveal Email/Phone
4
Development AssociateReveal Email/Phone
5
Brain Bank Liaison, Regional Coordinator, Support Group LeaderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$107.3M313-24%$25.5MN/A
#2
$1369.5M3623N/AN/AN/A
#3
$8.9M410%N/AN/A
#4
$49.6M167N/AN/AN/A
#5
$23.8M88-3%N/AN/A
#6
$13.1M548%N/AN/A
#7
$5.1M27N/AN/AN/A
#8
$14.8M6115%N/AN/A
#9
$8.6M4011%N/AN/A
#10
$9.5M4410%N/AN/A
Add Company

What Is Dystonia Medical Research Foundation?

Founded in 1976, the Dystonia Medical Research Foundation (DMRF) is a 501(c)3 organization dedicated to serving all people with dystonia and their families. Since its inception, the DMRF has grown from a small family-based foundation into a dynamic membership-driven organization led by a Board of Directors and network of volunteers with personal connections to dystonia. Because dystonia hits so close to home for our directors and volunteers, the DMRF leadership is motivated by an unrelenting drive to find a cure and an unwavering commitment to serving people affected by dystonia.

keywords:N/A

N/A

Total Funding

42

Number of Employees

$9.1M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M42-11%$132.6M
#2
$4.5M42-22%$31M
#3
$4.5M4211%$27M
#4
$7.5M4211%$1.3B
#5
$8.4M420%N/A